Portable Cd105 Monoclonal Antibody Synonyms Cd105 Device [FHxODchq]

CD105 Monoclonal Antibody: A Potent Tool for Research

The CD105 Monoclonal Antibody is a highly specialized research tool designed for the study of angiogenesis in various malignant tumor tissues. This antibody is engineered to specifically bind to CD105, a key protein in the TGF-β receptor signal transduction pathway and a proliferation-related antigen of vascular endothelial cells. With its mouse host origin and human reactivity, this antibody is a powerful addition to any research lab focused on understanding the complexities of tumor angiogenesis.

• High specificity for CD105 targets
• Mouse origin ensures compatibility with human tissue samples
• Reactivity to human samples allows for accurate research findings

Product Details and Specifications

The CD105 Monoclonal Antibody is produced using mouse cells, providing a reliable and consistent source for research applications. It is suitable for Immunohistochemistry (IHC-P) and offers excellent results in detecting CD105 in tissue samples. This antibody is localized to the cell membrane and has tissue specificity to the placenta, making it particularly useful in studying angiogenesis related to pregnancy and gynecological disorders. The product is stored at 2~8°C to maintain its stability and is valid for 12 months from the date of manufacture.

• Host: Mouse
• Reactivity: Human
• Applications: IHC-P
• Cellular Localization: Cell membrane
• Tissue Specificity: Placenta
• Storage: 2~8°C, RTU, protect from light, valid for 12 months

Applications and Benefits

The CD105 Monoclonal Antibody is an essential tool for researchers investigating the mechanisms of angiogenesis and tumor growth. Its high specificity and reactivity make it ideal for use in immunohistochemistry, allowing for detailed analysis of CD105 expression in tissue samples. This antibody can significantly enhance the accuracy and depth of research studies, particularly in the field of oncology. By using this product, researchers can gain valuable insights into the role of CD105 in angiogenesis and potentially identify new therapeutic targets for cancer treatment.

• Enhances the accuracy of research studies
• Facilitates the identification of new therapeutic targets
• Contributes to a better understanding of angiogenesis in malignant tumors